Home › Funds › Jones Hill Capital LP › CRBP

Jones Hill Capital LP position in CRBP

CORBUS PHARMACEUTICALS HLDGS · Health Care

Jones Hill Capital LP reported holding 886,428 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS) in its Q3 2026 13F filing — a position valued at US$6.0M, representing 1.03% of its reported portfolio and ranking #23 among its reported holdings. Jones Hill Capital LP has disclosed CRBP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)886.43K sh
Reported value held$6.05M
Portfolio Weight1.03%
First reportedQ2 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Jones Hill Capital LP's CRBP position evolved

Jones Hill Capital LP first disclosed a stake in CRBP in Q2 2026 at 653,572 shares (US$6.1M). Across 2 filings, Jones Hill Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 886,428 shares valued at US$6.0M — an increase of 232,856 shares quarter over quarter.. Notable position changes include a 36% increase in Q3 2026 (shares fell 50% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 653.57K $6.13M New
Q3 2026 886.43K $6.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRBP and 13F data

CRBP (CORBUS PHARMACEUTICALS HLDGS) is a Health Care company. 22 other funds we track also report a position in CRBP — the largest reported positions include Cormorant Asset Management, LP (US$22.0M), Prosight Management, LP (US$6.1M), Stonepine Capital Management, LLC (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRBP

All CRBP fund holders →

FAQ

How long has Jones Hill Capital LP held CRBP?

Jones Hill Capital LP has disclosed CRBP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Jones Hill Capital LP's current position in CRBP?

As of Q3 2026, Jones Hill Capital LP holds 886.43K shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), valued at $6.05M, representing 1.03% of its reported portfolio and ranking #23.

Has Jones Hill Capital LP been buying or selling CRBP?

In the latest 13F filing (Q3 2026), Jones Hill Capital LP increased its position in CRBP.

Which other funds hold CRBP?

Other major institutional holders of CRBP include Cormorant Asset Management, LP, Prosight Management, LP, Stonepine Capital Management, LLC, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.